H.C. Wainwright reiterates Korro Bio stock rating on trial dosing
All News
This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.
Read at original outlet ↗
RELATED COVERAGE
More from this desk.
BAGANBAZAR GRAPHSource-attributed newsBUSINESS deskBusiness
What PetroSA problems mean for the fuel you put in your car
R395bn infrastructure pipeline takes shape. Tutu Lecture asks what humanity demands of us now. And why older South Africans are becoming easier targets for digital fraud.
Original sourceMoneyweb↗
BAGANBAZAR GRAPHSource-attributed newsBUSINESS deskBusiness
Nvidia heads for $6trn value with chipmaker back at record
'Nvidia is attractive on both a growth basis and a value basis, and it looks like a haven from any damage higher rates could do to the economy,' said Jim Awad.
Original sourceMoneyweb↗
BAGANBAZAR GRAPHSource-attributed newsBUSINESS deskBusiness
Kenya confirms first Ebola patient came from Congo, died Monday
The crisis is driven by the rare Bundibugyo strain of Ebola, for which there are no approved vaccines or antibody treatments.
Original sourceMoneyweb↗